🚀 VC round data is live in beta, check it out!
- Public Comps
- Minimed Group
Minimed Group Valuation Multiples
Discover revenue and EBITDA valuation multiples for Minimed Group and similar public comparables like Samsung, Johnson & Johnson, Roche, Siemens and more.
Minimed Group Overview
About Minimed Group
Minimed Group Inc is a medical technology firm that develops, manufactures, and markets products and solutions for diabetes management. It offers automated insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens as its main products. The company sells these through direct-to-consumer channels and healthcare providers of various countries. The company's revenues are principally derived from the sale of reusable and single-use products which together comprise AID systems and smart multiple daily injection (MDI) systems for diabetes management to individuals, distributors, healthcare providers, and other institutions globally.
Founded
2025
HQ

Employees
8.0K
Website
Sectors
Financials (FY)
Market Cap
—
Minimed Group Financials
Minimed Group reported last fiscal year revenue of $3B and EBITDA of $107M.
In the same fiscal year, Minimed Group generated $2B in gross profit, $107M in EBITDA, and had net loss of ($250M).
Minimed Group P&L
In the most recent fiscal year, Minimed Group reported revenue of $3B and EBITDA of $107M.
Minimed Group expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $3B | XXX | XXX | XXX |
| Gross Profit | — | XXX | $2B | XXX | XXX | XXX |
| Gross Margin | — | XXX | 56% | XXX | XXX | XXX |
| EBITDA | — | XXX | $107M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 4% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (1%) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($250M) | XXX | XXX | XXX |
| Net Margin | — | XXX | (9%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Minimed Group Stock Performance
Minimed Group has current market cap of —.
| Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|
| — | — | XXX | XXX | XXX | — |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialMinimed Group Valuation Multiples
Minimed Group Financial Valuation Multiples
As of March 30, 2026, Minimed Group has market cap of —.
Equity research analysts estimate Minimed Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 |
|---|
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Minimed Group Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Minimed Group Margins & Growth Rates
Minimed Group's revenue in the last fiscal year grew by 3%.
Minimed Group's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.2M for the same period.
Minimed Group Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 3% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 4% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 17% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 42% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 16% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 57% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Minimed Group Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Samsung | XXX | XXX | XXX | XXX | XXX | XXX |
| Johnson & Johnson | XXX | XXX | XXX | XXX | XXX | XXX |
| Roche | XXX | XXX | XXX | XXX | XXX | XXX |
| Siemens | XXX | XXX | XXX | XXX | XXX | XXX |
| Abbott | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Minimed Group M&A Activity
Minimed Group acquired XXX companies to date.
Last acquisition by Minimed Group was on XXXXXXXX, XXXXX. Minimed Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Minimed Group
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialMinimed Group Investment Activity
Minimed Group invested in XXX companies to date.
Minimed Group made its latest investment on XXXXXXXX, XXXXX. Minimed Group invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Minimed Group
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Minimed Group
| When was Minimed Group founded? | Minimed Group was founded in 2025. |
| Where is Minimed Group headquartered? | Minimed Group is headquartered in United States. |
| How many employees does Minimed Group have? | As of today, Minimed Group has over 8K employees. |
| Is Minimed Group publicly listed? | Yes, Minimed Group is a public company listed on Nasdaq. |
| What is the stock symbol of Minimed Group? | Minimed Group trades under MMED ticker. |
| When did Minimed Group go public? | Minimed Group went public in 2050. |
| Who are competitors of Minimed Group? | Minimed Group main competitors are Samsung, Johnson & Johnson, Roche, Siemens. |
| What is the current revenue of Minimed Group? | Minimed Group's last fiscal year revenue is $3B. |
| Is Minimed Group profitable? | No, Minimed Group is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.